Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Frontiers in Immunology|December 27, 2016
Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qRLina Pednekar, Ansar A Pathan, Basudev Paudyal, et al.
BMC Infectious Diseases|December 4, 2014
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85ARachel Tanner, Kristina Kakalacheva, Ellen Miller, et al.
Frontiers in Immunology|June 6, 2018
Human Properdin Modulates Macrophage: Mycobacterium bovis BCG Interaction via Thrombospondin Repeats 4 and 5Maha Ahmed Al-Mozaini, Anthony G Tsolaki, Munirah Abdul-Aziz, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2009
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individualsClare R Sander, Ansar A Pathan, Natalie E R Beveridge, et al.
Tuberculosis (Edinburgh, Scotland)|September 20, 2008
A comparison of IFNgamma detection methods used in tuberculosis vaccine trialsNatalie E R Beveridge, Helen A Fletcher, Jane Hughes, et al.
European Journal of Immunology|October 20, 2007
Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populationsNatalie E R Beveridge, David A Price, Joseph P Casazza, et al.
Human Vaccines & Immunotherapeutics|November 13, 2012
Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trialRosalind Rowland, Ansar A Pathan, Iman Satti, et al.
BMJ Open|November 22, 2011
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsAngela M Minassian, Rosalind Rowland, Natalie E R Beveridge, et al.
Pageof 4